Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer


<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>To analyze the rate of larynx preservation in patients of locally advanced hypopharyngeal cancer treated with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy, and compare the results with patients treated with primary surgery.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Between January 2003 and November 2007, 14 patients were treated with primary surgery and 33 patients were treated with concurrent chemoradiotherapy (CCRT) using IMRT technique. Survival rate, larynx preservation rate were calculated with the Kaplan-Meier method. Multivariate analysis was conducted for significant prognostic factors with Cox-regression method.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>The median follow-up was 19.4 months for all patients, and 25.8 months for those alive. The 5-year overall survival rate was 33% and 44% for primary surgery and definitive CCRT, respectively (p = 0.788). The 5-year functional larynx-preservation survival after IMRT was 40%. Acute toxicities were common, but usually tolerable. The rates of treatment-related mucositis (≥ grade 2) and pharyngitis (≥ grade 3) were higher in the CCRT group. For multivariate analysis, treatment response and cricoid cartilage invasion strongly correlated with survival.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>IMRT plus concurrent chemotherapy may preserve the larynx without compromising survival. Further studies on new effective therapeutic agents are essential.</jats:p> </jats:sec>


  • Radiation Oncology

    Radiation Oncology 5 (1), 2010-05-15

    Springer Science and Business Media LLC

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top